HealthQuad announces the first close of its specialist healthcare focussed venture capital fund. The fund is focused on investing in early stage healthcare companies in India, through a pre-series A / Series A round of funding with ticket size range from INR 10million to INR 150million.
The fund plans to back transformative Indian healthcare platforms
, across healthcare delivery services and products that are expected to dramatically increase healthcare productivity, affordability, accessibility while improving patient health and fostering innovation.
Expanding on the rationale and opportunity, Dr. Amit Varma, one of the sponsors of the Fund, said ‘In the past few years the healthcare industry has witnessed umpteen disruptive business models which are evolving to change the landscape of the healthcare sector. These opportunities are mainly centred around technology backed services and products or theme based / niche healthcare business models. These models, while still at an early/ evolutionary stage in India, are expected to evolve and grow on the lines of their counterparts from developed market, who have attained penetration, proportion and size to attract attention of large healthcare players and investors.”
The funds, amongst the few healthcare focussed VC fund in Asia, is a Sebi registered AIF Category I target size and is managed by a team comprising of veterans from the healthcare and investing world.
The Fund’s investment strategy will be focused on investing in key healthcare subsectors namely healthcare delivery services, life sciences, devices and medical technology and health IT.
HealthQuad is a healthcare focussed venture capital fund which aims to invest in early stage healthcare companies in India, that are driven by new age disruptive technology or innovation and/or operate in a niche or theme based segment of the sector. HealthQuad seeks to make meaningful, positive impact by helping transform healthcare ventures to make paradigm positive change in healthcare productivity, affordability, accessibility while improving patient health and fostering innovation. The fund is sponsored by Dr. Amit Varma and Abrar Mir.